Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for targeted cancer therapies. Its enantiomeric purity is critical for optimal biological activity and selectivity in drug candidates. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) where the (R)-configuration enhances binding affinity to specific enzyme targets. Also utilized in research settings for the construction of nitrogen-containing heterocyclic compounds with potential neuroactive or anti-inflammatory properties.